Sage Therapeutics, Inc.

Erste Asset Management GmbH

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

28,500

Value ($000)

261

Weight

0.0%

2018 Q4 - 2025 Q2 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	261	0.0%	28,500	6/30/2025
2025 Q1	5/14/2025	236	0.0%	28,500	3/31/2025
2024 Q4	2/10/2025	158	0.0%	28,500	12/31/2024
2024 Q3	11/14/2024	208	0.0%	28,500	9/30/2024
2024 Q2	11/26/2024	305	0.0%	28,500	6/30/2024
2024 Q1	11/26/2024	543	0.0%	28,500	3/31/2024
2023 Q4	11/26/2024	629	0.0%	28,500	12/31/2023
2023 Q3	11/26/2024	591	0.0%	28,500	9/30/2023
2023 Q2	11/26/2024	1,339	0.0%	28,500	6/30/2023
2023 Q1	11/26/2024	1,194	0.0%	28,500	3/31/2023
2022 Q4	11/26/2024	1,102	0.0%	28,500	12/31/2022
2022 Q3	11/26/2024	1,129	0.0%	28,500	9/30/2022
2022 Q2	11/26/2024	935	0.0%	28,500	6/30/2022
2022 Q1	11/25/2024	977	0.0%	28,500	3/31/2022
2021 Q4	11/25/2024	510	0.0%	12,000	12/31/2021
2021 Q3	11/25/2024	1,479	0.0%	33,500	9/30/2021
2021 Q2	11/25/2024	1,889	0.0%	33,500	6/30/2021
2021 Q1	11/25/2024	2,455	0.1%	33,500	3/31/2021
2020 Q4	11/25/2024	2,920	0.1%	33,500	12/31/2020
2020 Q3	11/25/2024	1,116	0.0%	18,700	9/30/2020
2020 Q2	11/22/2024	781	0.0%	18,700	6/30/2020
2020 Q1	11/22/2024	552	0.0%	18,700	3/31/2020
2019 Q4	11/22/2024	1,372	0.1%	18,700	12/31/2019
2019 Q3	11/22/2024	4,882	0.3%	34,200	9/30/2019
2019 Q2	11/22/2024	6,171	0.3%	34,200	6/30/2019
2019 Q1	11/22/2024	6,201	0.3%	38,800	3/31/2019
2018 Q4	11/26/2024	3,120	0.2%	35,500	12/31/2018